More than 6 million adults in the US live with plaque psoriasis, but it’s often a misunderstood disease. Joining the discussion is actress entrepreneur Lala Anthony and dermatologist Dr. Meghan ...

Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...

This chronic condition that affects millions is often misunderstood or underappreciated in terms of its broader impact.

The actress and entertainment personality partnered with Amgen to share candid glimpses of how she lives with her medical ...

In early October, La La Anthony revealed to her 15 million followers that she has been battling with plaque psoriasis.

Imuldosa is used for the treatment of patients with autoimmune diseases such as plaque psoriasis, psoriatic arthritis, ...

This study aims to evaluate the efficacy and safety of picankibart for the treatment of moderately to severely active ulcerative colitis (modified Mayo score of 4 to 9 with an endoscopic subscore of ...

US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx: Brussels, Belgium Tuesday, October 15, 2024, 13:00 Hrs [IST] UCB, a global biopharmaceutical compa ...

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

InnoCare Pharma has announced that its Phase II study of the TYK2 inhibitor ICP-488 for psoriasis treatment met the primary ...

Imuldosa is the latest FDA-approved biosimilar of J&J’s blockbuster therapy for the treatment of certain autoimmune diseases.